Literature DB >> 15752155

Surface decoration of red blood cells with maleimidophenyl-polyethylene glycol facilitated by thiolation with iminothiolane: an approach to mask A, B, and D antigens to generate universal red blood cells.

Parimala Nacharaju1, Fouad N Boctor, Belur N Manjula, Seetharama A Acharya.   

Abstract

BACKGROUND: The surface decoration of red blood cells (RBCs) by polyethylene glycol (PEG) chains has been an approach developed to camouflage the blood group antigens from their antibodies. A PEGylation protocol, however, that can mask the antigens appropriately to inhibit the agglutination of RBCs with the respective antibodies is not available so far. STUDY DESIGN AND METHODS: A new approach for PEGylation of RBC membrane proteins has been designed with thiolation-mediated maleimide chemistry. The accessibility of the surface lysine residues of membrane proteins to bulky PEG reagents was increased by linking an extension arm carrying a thiol group.
RESULTS: RBCs have been PEGylated by thiolation-mediated chemistry with maleimidophenyl-PEG (Mal-Phe-PEG) reagents of different chain lengths. Mal-Phe-PEG-5000 chains alone masked the most important antigens of the Rh system (C, c, E, e, and D) from their antibodies. The masking of the A and B antigens needed a combination of Mal-Phe-PEG-5000 and Mal-Phe-PEG-20000 chains to inhibit the agglutination of RBCs completely with anti-A or anti-B.
CONCLUSIONS: Thiolation-mediated PEGylation of RBCs with Mal-Phe-PEG-5000 and Mal-Phe-PEG-20000 converts Group A Rh(D)+ and B Rh(D)+ RBCs into RBCs with serologic behavior comparable to Group O Rh(D)- RBCs that are considered as universal RBCs for transfusion.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15752155     DOI: 10.1111/j.1537-2995.2005.04290.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  7 in total

Review 1.  Challenges and emerging technologies in the immunoisolation of cells and tissues.

Authors:  John T Wilson; Elliot L Chaikof
Journal:  Adv Drug Deliv Rev       Date:  2007-10-11       Impact factor: 15.470

Review 2.  Drug delivery by red blood cells: vascular carriers designed by mother nature.

Authors:  Vladimir R Muzykantov
Journal:  Expert Opin Drug Deliv       Date:  2010-04       Impact factor: 6.648

Review 3.  Engineering the Surface of Therapeutic "Living" Cells.

Authors:  Jooyeon Park; Brenda Andrade; Yongbeom Seo; Myung-Joo Kim; Steven C Zimmerman; Hyunjoon Kong
Journal:  Chem Rev       Date:  2018-01-16       Impact factor: 60.622

4.  Cell surface engineering to control cellular interactions.

Authors:  Catarina A Custódio; João F Mano
Journal:  ChemNanoMat       Date:  2016-05       Impact factor: 3.154

Review 5.  Surface loading of nanoparticles on engineered or natural erythrocytes for prolonged circulation time: strategies and applications.

Authors:  Si-Qi Zhang; Qiang Fu; Yun-Jie Zhang; Jian-Xing Pan; Ling Zhang; Zhi-Rong Zhang; Zhen-Mi Liu
Journal:  Acta Pharmacol Sin       Date:  2021-03-26       Impact factor: 7.169

6.  Interaction of poly(ethylene glycol)-conjugated phospholipids with supported lipid membranes and their influence on protein adsorption.

Authors:  Toshihiro Yamamoto; Yuji Teramura; Toru Itagaki; Yusuke Arima; Hiroo Iwata
Journal:  Sci Technol Adv Mater       Date:  2016-10-18       Impact factor: 8.090

Review 7.  Nucleic Acid Delivery with Red-Blood-Cell-Based Carriers.

Authors:  Giulia Della Pelle; Nina Kostevšek
Journal:  Int J Mol Sci       Date:  2021-05-17       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.